Abstract
Objective Increasing the availability of non-alcoholic options is a promising population-level intervention to reduce alcohol consumption, currently unassessed in naturalistic settings. This study in an online retail setting aimed to estimate the impact of increasing the proportion of non-alcoholic (relative to alcoholic) drinks, on selection and actual purchasing of alcohol.
Design Parallel-group randomised controlled trial.
Setting Participants selected drinks in a simulated online supermarket, before purchasing them in an actual online supermarket.
Participants Adults in England and Wales who regularly consumed and purchased beer and wine online (n=737).
Intervention Participants were randomised to one of three groups: Higher Proportion of non-alcoholic drinks available (75%); Same Proportion (50%); Lower Proportion (25%).
Main outcome measure The primary outcome was the number of alcohol units selected (with intention to purchase); secondary outcomes included purchasing.
Results 607 participants completed the study and were included in the primary analysis. The Higher Proportion group selected 10.0 fewer alcohol units than the Lower Proportion group (−32%; 95%CI -42%,-22%) and 7.1 fewer units compared to the Same Proportion group (−25%; 95%CI -36%,-13%), based on model results in those selecting any drinks containing alcohol (559/607). There was no evidence of a difference between the Same Proportion and Lower Proportion groups (2.9 fewer units, -9%; 95%CI -22%,5%). For all other outcomes, alcohol selection and purchasing were consistently lowest in the Higher Proportion group.
Conclusion This study provides evidence that substantially increasing the proportion of non-alcoholic drinks - from 25% to 50% or 75% - meaningfully reduces alcohol selection and purchasing. Further studies are warranted to assess whether these effects are realised in a range of real-world settings.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
ISRCTN:11004483
Clinical Protocols
Funding Statement
This research was funded in whole, or in part, by the Wellcome Trust [ref: 206853/Z/17/Z].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Faculty of Life Sciences Research Ethics Committee at the University of Bristol (reference no: 116124) gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Trial registration ISRCTN:11004483; OSF: https://osf.io/qfupw
Data Availability
Data will be available from the Open Science Framework (together with the study protocol and statistical analysis plan, already uploaded) and the University of Cambridge Research Repository upon publication.